Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|October 3, 2018
[Influence of primary lymph node status of colorectal cancer on the development of pulmonary metastases and thoracic lymph node metastases]H-S Hofmann, C Doblinger, T Szöke, et al.
The Thoracic and Cardiovascular Surgeon|June 22, 2011
Surgical resection of thymoma still represents the first choice of treatmentM Ried, H Guth, T Potzger, et al.
Pneumologie (Stuttgart, Germany)|January 20, 2021
[Organ Bath Experiments on Human Pulmonary Vessels: Assessment of Drug Efficacy for Treatment of Pulmonary Arterial Hypertension]C Stadlbauer, S Golovchenko, L Englert, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 8, 2013
[Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg]M Ried, U Speth, T Potzger, et al.
Journal of Surgical Oncology|February 7, 2013
Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignanciesM Ried, T Potzger, N Braune, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|May 6, 2016
[Surgical reconstructive procedures of the chest wall after mediastinitis]M Ried, S Geis, T Potzger, et al.
Zentralblatt Fur Chirurgie|February 11, 2016
[Outcomes of Stage-Adapted Surgical Treatment of Pleural Empyema]Z Sziklavari, J I Graml, F Zeman, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 18, 2013
[The competent surgeon. Bridging the gap between undergraduate final year and postgraduate surgery training]M Kadmon, P Ganschow, S Gillen, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|November 26, 2013
Intraoperative sRAGE kinetics. A new age-related outcome predictor of cardiac surgeryA Simm, C Philipp, I Friedrich, et al.
Pulmonary Pharmacology & Therapeutics|December 28, 2020
Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath modelL Englert, C Stadlbauer, M Spaeth, et al.
Pageof 4